CHOLESTYRAMINE (Cadila Healthcare Limited)
Welcome to the PulseAid listing for the CHOLESTYRAMINE drug offered from Cadila Healthcare Limited. This Bile Acid Sequestrant [EPC],Bile-acid Binding Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Cadila Healthcare Limited |
| NON-PROPRIETARY NAME: | CHOLESTYRAMINE |
| SUBSTANCE NAME: | CHOLESTYRAMINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Bile Acid Sequestrant [EPC],Bile-acid Binding Activity [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | POWDER, FOR SUSPENSION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-06-08 |
| END MARKETING DATE: | 0000-00-00 |
CHOLESTYRAMINE HUMAN PRESCRIPTION DRUG Details:
| Item Description | CHOLESTYRAMINE from Cadila Healthcare Limited |
| LABELER NAME: | Cadila Healthcare Limited |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 4(g/5.5g) |
| START MARKETING DATE: | 2017-06-08 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70771-1070_f2fc77b5-4ac9-469a-b2c2-4ba2c8b05a3b |
| PRODUCT NDC: | 70771-1070 |
| APPLICATION NUMBER: | ANDA202902 |
Other CHOLESTYRAMINE Pharmaceutical Manufacturers / Labelers:
